114 related articles for article (PubMed ID: 29334750)
1. [Remission of steroid-resistant Stills disease treated with anakinra, evidenced by FDG-PET/CT examination: case report].
Adam Z; Skřičková J; Krtička M; Řehák Z; Koukalová R; Šprláková A; Krejčí M; Pour L; Adamová Z; Pourová E; Král Z
Vnitr Lek; 2018; 63(12):987-997. PubMed ID: 29334750
[TBL] [Abstract][Full Text] [Related]
2. Anakinra injection site reaction on FDG PET/CT.
Arens AI; Vriens D; Janssen M; Simon A; Oyen WJ
Clin Nucl Med; 2015 Jun; 40(6):492-3. PubMed ID: 25742228
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of five years of treatment of Erdheim-Chester disease with anakinra: case report and overview of literature].
Adam Z; Petrášová H; Řehák Z; Koukalová R; Krejčí M; Pour L; Vetešníková E; Čermák A; Ševčíková S; Szturz P; Král Z; Mayer J
Vnitr Lek; 2016; 62(10):820-832. PubMed ID: 27900869
[TBL] [Abstract][Full Text] [Related]
4. Successful outcome of two pregnancies in patients with adult-onset Still's disease treated with IL-1 receptor antagonist (anakinra).
Fischer-Betz R; Specker C; Schneider M
Clin Exp Rheumatol; 2011; 29(6):1021-3. PubMed ID: 22153586
[TBL] [Abstract][Full Text] [Related]
5. A SEVERE CASE OF ADULT ONSET STILLS DISEASE WITH MYOPERICARDITIS, RESISTANT TO TREATMENT WITH TOCILIZUMAB BUT RESPONSIVE TO ANAKINRA.
Waghmare S; Valecka B; Cairns AP
Ulster Med J; 2015 May; 84(2):130-2. PubMed ID: 26376493
[No Abstract] [Full Text] [Related]
6. FDG-PET/CT findings in adult-onset Still's disease.
Yaguchi D; Inoue N; Koike W; Kimura H; Ichikawa M
QJM; 2019 Sep; 112(9):705-706. PubMed ID: 30828734
[No Abstract] [Full Text] [Related]
7. Marked effect and steroid-sparing ability of anakinra on a patient with refractory adult-onset Still's disease.
Tamaki H; Shimizu H; Hiraoka E; Uechi E; Kishimoto M; Yamaguchi K; Okada M
Mod Rheumatol; 2010 Apr; 20(2):200-4. PubMed ID: 20037747
[TBL] [Abstract][Full Text] [Related]
8. Clinical value of ¹⁸F-fluoro-dexoxyglucose positron emission tomography/computed tomography in patients with adult-onset Still's disease: a seven-case series and review of the literature.
Yamashita H; Kubota K; Takahashi Y; Minamimoto R; Morooka M; Kaneko H; Kano T; Mimori A
Mod Rheumatol; 2014 Jul; 24(4):645-50. PubMed ID: 24252024
[TBL] [Abstract][Full Text] [Related]
9. ¹⁸F-FDG PET/CT aids the diagnosis of adult onset Still's disease in a patient with fever of unknown origin.
Roy SG; Karunanithi S; Dhull VS; Bal C; Kumar R
Rev Esp Med Nucl Imagen Mol; 2014; 33(6):392-3. PubMed ID: 25242172
[No Abstract] [Full Text] [Related]
10. 18F-FDG PET/CT in patients with adult-onset Still's disease.
Dong MJ; Wang CQ; Zhao K; Wang GL; Sun ML; Liu ZF; Xu L
Clin Rheumatol; 2015 Dec; 34(12):2047-56. PubMed ID: 25711875
[TBL] [Abstract][Full Text] [Related]
11. Effective treatment of steroid refractory adult-onset Still's disease with anakinra.
Maier J; Birkenfeld G; Pfirstinger J; Schölmerich J; Fleck M; Brühl H
J Rheumatol; 2008 May; 35(5):939-41. PubMed ID: 18464320
[No Abstract] [Full Text] [Related]
12. [Anakinra in refractory adult onset Still's disease].
Vercoutere W; Starmans-Kool M; Peeters RM
Ned Tijdschr Geneeskd; 2011; 155(18):A2966. PubMed ID: 21466723
[TBL] [Abstract][Full Text] [Related]
13. Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial.
Kalliolias GD; Georgiou PE; Antonopoulos IA; Andonopoulos AP; Liossis SN
Ann Rheum Dis; 2007 Jun; 66(6):842-3. PubMed ID: 17513574
[No Abstract] [Full Text] [Related]
14. Early use of anakinra in adult-onset Still's disease myocarditis.
Piel-Julian ML; Moulis G; Fournier P; Dupont R; Geiger D; Astudillo L; Faurie T; Pozzo J; Petermann A; Lairez O; Pugnet G; Sailler L
Scand J Rheumatol; 2018 Nov; 47(6):511-512. PubMed ID: 29291663
[No Abstract] [Full Text] [Related]
15. Severe systemic inflammatory response syndrome in a patient with adult onset Still's disease treated with the anti-IL1 drug anakinra: a case report.
Guignard S; Dien G; Dougados M
Clin Exp Rheumatol; 2007; 25(5):758-9. PubMed ID: 18078628
[TBL] [Abstract][Full Text] [Related]
16. Clinical, biological and sonographic response to IL-1 blockade in adult-onset Still's disease.
Priori R; Ceccarelli F; Barone F; Iagnocco A; Valesini G
Clin Exp Rheumatol; 2008; 26(5):933-7. PubMed ID: 19032833
[No Abstract] [Full Text] [Related]
17. Adult-onset Still's disease in a patient with cystic fibrosis and its successful treatment with anakinra.
Albersmeyer MP; Hilge RG; Schulze-Koops H; Sitter T
Rheumatology (Oxford); 2012 Sep; 51(9):1730-2. PubMed ID: 22513144
[No Abstract] [Full Text] [Related]
18. Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still's disease. An open, randomized, multicenter study.
Nordström D; Knight A; Luukkainen R; van Vollenhoven R; Rantalaiho V; Kajalainen A; Brun JG; Proven A; Ljung L; Kautiainen H; Pettersson T
J Rheumatol; 2012 Oct; 39(10):2008-11. PubMed ID: 22859346
[TBL] [Abstract][Full Text] [Related]
19. Anakinra in adult-onset Still's disease: long-term treatment in patients resistant to conventional therapy.
Giampietro C; Ridene M; Lequerre T; Costedoat Chalumeau N; Amoura Z; Sellam J; Sibilia J; Bourgeois P; Fautrel B;
Arthritis Care Res (Hoboken); 2013 May; 65(5):822-6. PubMed ID: 23225779
[TBL] [Abstract][Full Text] [Related]
20. Adult-onset Still's disease with myocarditis successfully treated with the interleukin-1 receptor antagonist anakinra.
Raffeiner B; Botsios C; Dinarello C; Ometto F; Punzi L; Ramonda R
Joint Bone Spine; 2011 Jan; 78(1):100-1. PubMed ID: 21036649
[No Abstract] [Full Text] [Related]
[Next] [New Search]
